Terms: = Ovarian cancer AND ACSL3, PRO2194, 2181, ENSG00000123983, O95573, FACL3, ACS3 AND Treatment
6 results:
1. Identification and prioritization of tumour-associated antigens for immunotherapeutic and diagnostic capacity in epithelial ovarian cancer: a systematic literature review.
Wiseman L; Cinti N; Guinn BA
Carcinogenesis; 2022 Dec; 43(11):1015-1029. PubMed ID: 36318800
[TBL] [Abstract] [Full Text] [Related]
2. The use of bevacizumab is correlated with improved post-progression survival in advanced recurrent ovarian cancer.
Yanazume S; Ushiwaka T; Fukuda M; Togami S; Kamio M; Kobayashi H
Jpn J Clin Oncol; 2021 Aug; 51(9):1407-1415. PubMed ID: 34240168
[TBL] [Abstract] [Full Text] [Related]
3. Annual report of the committee on gynecologic oncology, the Japan Society of Obstetrics and Gynecology: Annual patients report for 2015 and annual treatment report for 2010.
Nagase S; Ohta T; Takahashi F; Enomoto T;
J Obstet Gynaecol Res; 2019 Feb; 45(2):289-298. PubMed ID: 30426591
[TBL] [Abstract] [Full Text] [Related]
4. Current detection rates and time-to-detection of all identifiable
Manchanda R; Blyuss O; Gaba F; Gordeev VS; Jacobs C; Burnell M; Gan C; Taylor R; Turnbull C; Legood R; Zaikin A; Antoniou AC; Menon U; Jacobs I
J Med Genet; 2018 Aug; 55(8):538-545. PubMed ID: 29622727
[TBL] [Abstract] [Full Text] [Related]
5. A phase II trial of carboplatin and docetaxel followed by radiotherapy given in a "Sandwich" method for stage III, IV, and recurrent endometrial cancer.
Geller MA; Ivy JJ; Ghebre R; Downs LS; Judson PL; Carson LF; Jonson AL; Dusenbery K; Vogel RI; Boente MP; Argenta PA
Gynecol Oncol; 2011 Apr; 121(1):112-7. PubMed ID: 21239048
[TBL] [Abstract] [Full Text] [Related]
6. Protective effect of chorionic gonadotropin on DMBA-induced mammary carcinogenesis.
Russo IH; Koszalka M; Gimotty PA; Russo J
Br J Cancer; 1990 Aug; 62(2):243-7. PubMed ID: 2117463
[TBL] [Abstract] [Full Text] [Related]